Screener
Artiva Biotherapeutics, Inc. ARTV PP&E (Net)
PP&E (Net) at other companies
Other financials
Where this comes from
Reported directly by Artiva Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentNet.
The source filing: Artiva Biotherapeutics, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:12 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-338029
| Line item | AS OF / JUNE 30,2026 | AS OF / DECEMBER 31,2025 |
|---|---|---|
| Prepaid expenses and other current assets | 2,741 | 4,591 |
| Total current assets | 352,276 | 112,666 |
| Restricted cash | 461 | 461 |
| Property and equipment, net | 5,671 | 6,618 |
| Operating lease right-of-use assets | 9,236 | 10,525 |
| Financing lease right-of-use asset | 180 | 212 |
| Other long-term assets | 809 | 458 |
| Total assets | $368,633 | $130,940 |
Item 1. Financial Statements
FAQ
- What is Artiva Biotherapeutics, Inc.'s PP&E (net)?
- Artiva Biotherapeutics, Inc. (ARTV) reported PP&E (net) of $5.67M in Q2 2026.
- How has Artiva Biotherapeutics, Inc.'s PP&E (net) changed year-over-year?
- Artiva Biotherapeutics, Inc.'s PP&E (net) decreased by 17.6% year-over-year, from $6.89M to $5.67M.
- What is the long-term trend for Artiva Biotherapeutics, Inc.'s PP&E (net)?
- Over 2 years (2023 to 2025), Artiva Biotherapeutics, Inc.'s PP&E (net) has grown at a -9.6% compound annual growth rate (CAGR), from $8.1M to $6.62M.
- What does PP&E (net) mean?
- Total property, plant, and equipment minus accumulated depreciation — the net book value of all tangible long-lived assets.
Ask your AI about Artiva Biotherapeutics, Inc.'s pp&e (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude